TAS-0286

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameTAS-0286
Drug Alias NameRET inhibitor (Taiho Pharmaceutical/Helsinn Healthcare)HM-05TAS-0286
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase receptor RET inhibitorsAnticancer protein kinase inhibitors
TargetsTyrosine-protein kinase receptor RET
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTaiho Pharmaceutical Co LtdHelsinn Healthcare Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A